Referanslar

• World Health Organization, Priority Eye Diseases, Age Related Macular Degeneration,Magnitude; http:// www.who.int/blindness/causes/priority/en/index8.html
• National Eye Institute, Facts About Age Related Macular Degeneration, www.nei.nih.gov/health/maculardegen/ armd_facts.asp
• AMD Alliance International, www.amdalliance.org/
• AMD Macular Degeneration Partnership, www.amd.org/
• www.lucentis.com
• Williams RA, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998; 116:514-520.
• Brown MM, et al. Age-related macular degeneration: Can J Ophthalmol. 2005; 40:277-287.
• AMD alliance AMD & depression, finding support. Available at: www.amdalliance.org/information/depression/ findingsupport.php Accessed 08/02/08.
• Lucentis® summary of product characteristics. Basel, Switzerland: Novartis AG; 2006.
• Mitchell P, et al. The Blue Mountains Eye Study'. Arch Ophthalmol 2002: 120: 1357-1363.
• MD foundation fact sheet booklet. Available at: www.mdfoundation.com.au/resources/1/Final%20Booklet.pdf Accessed 25/01/08.
• MedlinePlus Medical Encyclopedia: Home Vision Tests. Available at www.nlm.nih.gov/medlineplus/ency/ article/003446.htm Accessed 25/02/08.
• CNIB Caregivers handbook. www.amdalliance.org/documents/2_5_1_Caregivers_Handbook.pdf
• http://www.mdfoundation.com.au/resources/1/How%20is%20MD%20Diagnosed%20(web).pdf
• National Eye Institute (US). Age-related macular degeneration: what you should know. Available at: www.nei.nih.gov/health/maculardegen/armd_facts.asp Accessed 02/07/07.
• Buch H, et al. Acta Ophthalmol Scand. 2005; 83: 409-418.
• Age-Related Eye Disease Study Research Group. AREDS report no. 8. Arch Ophthalmol. 2001 Oct; 119: 1417-36.
• National Eye Institute (US) press release: Available at: www.nei.nih.gov/news/pressreleases/101201.asp Accessed 13/03/08
• Mitchell P, et al. The Blue Mountains Eye Study'. Arch Ophthalmol 2002: 120: 1357-1363.
• RNIB – Older People and Eye Tests. Don't let older age rob you of sight. Campaign document 2007.
• http://www.mdfoundation.com.au/resources/5/19649_MDF_Guide_Draft7.pdf
• Kaiser PK, Do DV et al. Ranibizumab for the treatment of Neovascular AMD. Int J Clin Pract 2007, 61(3): 501-509
• Parmet S et al. JAMA. 24/05/06; 295: 2438.
• LUCENTIS® summary of product characteristics. Basel, Switzerland: Novartis AG; 2006.
• Rosenfeld PJ, et al. N Engl J Med. 05/10/06; 355: 1419-31.
• Genentech (2007) Lucentis, treatment for age-related macular degeneration: What is Lucentis. Available at: www.lucentis.com/lucentis/what_is_lucentis.jsp Accessed 24/01/08.
• Brown DM, et al. Ophtalmology 2009; 116: 57-65
• Regillo CD et al. Am J Ophthalmol. 2008; 145(2): 239-248.